Intuitive Surgical Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its da Vinci 5 system to be used in certain cardiac procedures. The approved indications include mitral valve repair, internal mammary artery $(IMA)$ mobilization for cardiac revascularization, patent foramen ovale closure, atrial septal defect repair, left atrial appendage closure/occlusion, atrial myxoma excision, mitral valve replacement, tricuspid valve repair, and epicardial pacing lead placement. The clearance allows selected U.S. sites to begin implementing da Vinci 5 cardiac programs, supported by specialized training and infrastructure developed by Intuitive.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intuitive Surgical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9642434-en) on January 26, 2026, and is solely responsible for the information contained therein.